Sens. Durbin and Grass­ley lever­age Medicare drug ne­go­ti­a­tion list to rein­vig­o­rate a push for drug prices in ads

Two high-rank­ing sen­a­tors are once again push­ing to force phar­ma com­pa­nies to in­clude the price of drugs in di­rect-to-con­sumer ad­ver­tis­ing.

Sens. Dick Durbin (D-IL) and Chuck Grass­ley (R-IA) are re­new­ing long­stand­ing ef­forts, with Grass­ley fil­ing their co-spon­sored “Drug-price Trans­paren­cy for Con­sumers Act of 2023” as an amend­ment to the Fi­nance Com­mit­tee’s mark-up in Ju­ly, a Durbin spokesper­son told End­points News. Mean­while, Durbin cap­i­tal­ized on the at­ten­tion to the Medicare drug price ne­go­ti­a­tion list an­nounced Tues­day with a call-to-ac­tion post on X, for­mer­ly known as Twit­ter.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER